Ace Alzheimer Center participates in the Barcelona Strategy for Alzheimer’s and Other Dementias 2025-2030

Barcelona is taking a step forward with the Barcelona per l’Alzheimer strategy, a pioneering initiative that seeks to make the city a benchmark in awareness, prevention, guidance, support, and research in the field of Alzheimer’s and dementia. The aim is to improve the quality of life of those affected and their families through a coordinated and inclusive network that places dignity, equity, and community support at the center of its actions.

As part of this strategy, a round table discussion was held on September 16, featuring professionals from different fields related to health, social care, and research. Among them, Dr. Mercè Boada, co-founder and medical director of Ace, shared her views on the importance of early detection and promoting research as a driver of change.

Dr. Boada highlighted the need to work together in clinical and social research to offer real answers to people living with the disease and their families. “Barcelona has the opportunity to lead a unique model based on prevention and collective commitment to Alzheimer’s and dementia,” said Dr. Boada.

She added that Barcelona must focus on older people and adapt the city to the needs of this group. Early detection and personalized medicine, which are necessary for more accurate and timely diagnoses, must not be overlooked either.

Other authorities also participated, including Jaume Collboni, Mayor of Barcelona; Marta Villanueva, Councilor for Health, People with Disabilities, and Strategy Against Loneliness; and Rosa Badia, journalist and host of the event.

Ace Alzheimer Center, as a leading institution in diagnosis and treatment, actively participates in the HUB Alzheimer Barcelona, a collaborative space that brings together the city’s main hospitals and research centers. Our commitment is clear: to contribute our knowledge and experience to enable Barcelona to consolidate its position as an international capital for research and care in Alzheimer’s and other dementias.